Dive Into Dollar Tr...
Health Care: Drugs
Allergan Inc. (AGN: NYSE)
$101.41 0.99 | 0.99%
05/17/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 1.10B | 938.10M | 4.90M | 623.80M |
| Operating Gains/Losses | 5.70M | 5.90M | 15.50M | 31.60M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -34.30M | -105.60M | -71.40M | -17.70M |
| (Increase) Decrease in Inventories | -7.30M | -24.00M | -5.60M | 67.70M |
| (Increase) Decrease In Other Current Assets | -16.00M | -33.10M | -11.30M | -15.40M |
| (Decrease) Increase In Payables | 32.70M | -19.30M | 8.60M | 22.50M |
| (Decrease) Increase In Other Current Liabilities | 125.50M | 19.30M | 11.70M | 56.00M |
| (Increase) Decrease In Other Working Capital | 70.80M | 200.00K | 0.00 | 0.00 |
| Other Non-Cash Items | 157.80M | 107.50M | 476.40M | 169.30M |
| Net Cash From Continuing Operations | 1.60B | 1.08B | 463.90M | 1.11B |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 1.60B | 1.08B | 463.90M | 1.11B |
| Sale of Property, Plant & Equipment | 1.80M | 1.20M | 400.00K | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 784.60M | 1.14B | 75.00M | 0.00 |
| Purchases of Property, Plant & Equipment | -161.30M | -130.10M | -157.00M | -125.70M |
| Acquisitions | -349.20M | -101.40M | -69.80M | -12.80M |
| Purchases of Short-Term Investments | -865.20M | -571.10M | -824.10M | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | -1.70M | 11.60M |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -589.30M | 340.80M | -977.20M | -98.70M |
| Issuance of Debt | 0.00 | 0.00 | 648.00M | 12.10M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 246.40M | 264.00M | 234.00M | 63.50M |
| Repayment of Long-Term Debt | 0.00 | -808.90M | 0.00 | -98.30M |
| Repurchase of Capital Stock | -909.00M | -461.70M | -286.00M | -105.50M |
| Payment of Cash Dividends | -60.40M | -61.10M | -60.60M | -60.60M |
| Other Financing Charges, Net | 5.50M | 65.40M | 27.60M | 7.30M |
| Net Cash From Financing Activities | -717.50M | -1.00B | 563.00M | -181.50M |
| Effect of Exchange Rate Changes | 2.60M | -5.50M | -5.60M | 3.60M |
| Net Change in Cash & Cash Equivalents | 295.70M | 414.90M | 44.10M | 836.70M |
Portfolios with AGN
- Portfolio NameUser Type
- ProRay Dalio - Bridgewater Ass...
- ContributorHigh Volume Technicals for ...
- ContributorTechnical Setups for the We...
- UserOil/Gas Feb 2012
- Contributor7 Stocks Set To Rise at Lea...
- UserCLUBCAR47 Portfolio 1
- UserLes's Picks
- ProBridger Management
- ContributorTop 20 Stocks With Large Se...
- ContributorRocket Stocks for the Week ...
Latest AGN Headlines from TheStreet
- Cramer Talks Abbott & Glaxo
04.17.13 | 03:04 pm - Allergan Reaches New 52-Week High (AGN) 04.11.13 | 10:04 am
- Allergan Inc. Stock Buy Recommendation Reiterated (AGN) 04.11.13 | 10:04 am
- Allergan Becomes #172 Most Shorted S&P 500 Component, Replacing Emerson Electric 04.10.13 | 03:04 pm
- Allergan Reaches New 52-Week High (AGN) 04.02.13 | 11:04 am
- Allergan Inc. Stock Buy Recommendation Reiterated (AGN) 04.01.13 | 10:04 am
- Cramer's 'Mad Money' Recap: Shift Your Perspective 03.27.13 | 08:03 pm
- Allergan Reaches New 52-Week High (AGN) 03.26.13 | 10:03 am
- Allergan Inc. Stock Buy Recommendation Reiterated (AGN) 03.19.13 | 10:03 am
- 5 Stocks Pushing The Health Care Sector Higher 03.11.13 | 01:03 pm
Press Releases for AGN
- Allergan, Inc. Announces Expiration Of Tender Offer For All Outstanding Shares Of MAP Pharmaceuticals, Inc. And Intent To Exercise Top-Up Option To Effect A Short-Form Merger - Business Wire 03.01.13 | 09:03 am
- FDA Approves Natrelle® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants - Business Wire 02.20.13 | 06:02 pm
- Allergan, Inc. And MAP Pharmaceuticals, Inc. Announce The Federal Trade Commission Has Granted Early Termination Of Waiting Period Under Hart-Scott-Rodino Act - Business Wire 02.07.13 | 09:02 am
- Allergan Reports Fourth Quarter 2012 Operating Results - Business Wire 02.05.13 | 09:02 am
- Allergan Commences Cash Tender Offer For All Outstanding Shares Of MAP Pharmaceuticals - Business Wire 01.31.13 | 09:01 am
- The Law Firm Of Levi & Korsinsky, LLP Notifies Investors Of Claims Of Breaches Of Fiduciary Duty By The Board Of MAP Pharmaceuticals Inc. In Connection With The Sale Of The Company To Allergan Inc. - PR Newswire 01.25.13 | 03:01 pm
- MAP Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Allergan, Inc. - PR Newswire 01.23.13 | 11:01 am
- Allergan, Inc. To Acquire MAP Pharmaceuticals, Inc. - Business Wire 01.22.13 | 08:01 pm
- BOTOX(R) (onabotulinumtoxinA) Receives U.S. Food And Drug Administration Approval For The Treatment Of Overactive Bladder For Adults Who Have An Inadequate Response To Or Are Intolerant Of An Anticholinergic Medication - Business Wire 01.18.13 | 05:01 pm
- Allergan Announces Quarterly Conference Call - Business Wire 01.07.13 | 05:01 pm
Partner Headlines for AGN
- Regeneron's Eylea Drives Astounding Q1 Results - Investor's Business Daily 05.10.13 | 06:05 pm
- Leading Biotechs Act Well But Be Careful Not To Chase - Investor's Business Daily 05.06.13 | 06:05 pm
- Starbucks, Huntington Bancshares and Other Stocks Insiders Are Buying - Benzinga 05.04.13 | 10:05 am
- Stocks Rally On Jobs Data; IBD 50 Names Assert Leadership - Investor's Business Daily 05.03.13 | 01:05 pm
- Futures Surge On Jobs Data; Regeneron, Fleetcor Lean Higher - Investor's Business Daily 05.03.13 | 09:05 am
- Stocks Pull Back In Higher Turnover, But Regeneron Soars - Investor's Business Daily 05.01.13 | 04:05 pm
- Stocks In Give-Back Mode; Spirit Air Flies, MasterCard Off - Investor's Business Daily 05.01.13 | 01:05 pm
- Weak Data Hamstring Stocks; Regeneron Pharmaceuticals Soars - Investor's Business Daily 05.01.13 | 12:05 pm
- Pre-Market Earnings Report for May 1, 2013 : MRK, CMCSA, CVS, MA, TWX, AGN, AMT, EXC, VIAB, DVN, DLPH, CHK - NASDAQ 04.30.13 | 08:04 pm
- Apple Leads Tech Stock Rally; New All-Time High For S&P 500 - Investor's Business Daily 04.30.13 | 05:04 pm
